Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-006901
Filing Date
2022-05-02
Accepted
2022-05-02 17:08:13
Documents
56
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q axsm-20220331.htm   iXBRL 10-Q 1981074
2 EX-10.1 axsm-ex10_1.htm EX-10.1 1163667
3 PDF COURTESY COPY axsm-ex10_1.pdf EX-10.1 2044124
4 EX-31.1 axsm-ex31_1.htm EX-31.1 18294
5 EX-31.2 axsm-ex31_2.htm EX-31.2 18112
6 EX-32.1 axsm-ex32_1.htm EX-32.1 8328
7 EX-32.2 axsm-ex32_2.htm EX-32.2 8333
  Complete submission text file 0000950170-22-006901.txt   10768620

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axsm-20220331_lab.xml EX-101.LAB 427458
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axsm-20220331_cal.xml EX-101.CAL 34644
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axsm-20220331_pre.xml EX-101.PRE 282847
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axsm-20220331_def.xml EX-101.DEF 145491
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axsm-20220331.xsd EX-101.SCH 49149
50 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20220331_htm.xml XML 977556
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37635 | Film No.: 22883102
SIC: 2834 Pharmaceutical Preparations